Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin

PTSF63 – The Media and Legalization, Joints for Jabs, and 40,000...

Atai Targets $2.3bn Valuation in Nasdaq IPO

atai Life Sciences Announces Launch of Initial Public Offering

LSD and the Anarchic Brain

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit...

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom...

PharmaTher Provides Research and Development Update and Milestones for 2021

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder...

Filament Cultivates 20th Psychedelic Mushroom Variety and Provides Propagation Update

Load more